ABL Bio

2nd Floor, 16 Daewangpangyo-Ro 712 Beon-Gil, Seongnam-Si, Gyeonggi-Do, 13488, South Korea

Overview

Biotech company developing therapeutic drugs for immuno-oncology.

Total Raised

$15 M

Rounds

Links

Website LinkedIn

Verticals

Biotechnology

Health Care

Medical

Investment History

Other Equity

Dec 2025$15 M

Investors


	Lead	—	Indianapolis, IN, USA

USALead

Funding Timeline

Rounds without known dates remain in the investment history. Unknown amounts are listed separately and excluded from disclosed totals; zero indicates no recorded funding that month.

ABL Bio has $15,000,000 in disclosed funding across the plotted months. Available history
Month (UTC)	Disclosed funding (USD)	Rounds with undisclosed amounts (count)
Dec 25	15,000,000	0
Jan 26	0	0
Feb 26	0	0
Mar 26	0	0
Apr 26	0	0
May 26	0	0
Jun 26	0	0
Jul 26	0	0
Aug 26	0	0
Sep 26	0	0
Oct 26	0	0

Team

Sang Hoon Lee

CEO/Founder